Detalles de la búsqueda
1.
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.
BMC Cancer
; 23(1): 416, 2023 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37158833
2.
PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours.
Acta Pharmacol Sin
; 43(9): 2373-2385, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35046516
3.
The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma.
J Surg Oncol
; 118(1): 31-36, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29878378
4.
Individualised tailored assessment of therapeutic alternatives for HCC patients within the Milan criteria.
Gut
; 69(10): 1893-1895, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31748202
5.
Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
Gastroenterology
; 143(6): 1641-1649.e5, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22922424
6.
Comparison of the long-term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation.
Cancer Med
; 12(3): 2312-2324, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36016484
7.
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.
Liver Cancer
; 12(3): 262-276, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601982
8.
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study.
Cancer Med
; 12(4): 4137-4146, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36127767
9.
A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
Front Oncol
; 12: 946531, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35936698
10.
Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
Yonsei Med J
; 62(1): 29-40, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33381932
11.
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection.
Chin Med J (Engl)
; 130(22): 2650-2660, 2017 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133751
12.
Neutrophil-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib.
Med Oncol
; 31(6): 969, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24793745
13.
Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis.
Mol Clin Oncol
; 2(6): 1125-1134, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25279210
Resultados
1 -
13
de 13
1
Próxima >
>>